HOPCo has entered yet another state through the formation of a partnership with Reno-based Spine Nevada and its affiliated brands, Swift Urgent Clinic and Vein Nevada, known as HOPCo Nevada. This will create an innovative platform for integrated musculoskeletal and vein care throughout Nevada.

HOPCo has announced that Osmel “Ozzie” Delgado will now lead the company as Chief Operating Officer. Prior to joining HOPCo, Ozzie served as the Chief Operating Officer for Cleveland Clinic Florida since 2014. As the Chief Operating Officer at HOPCo, his role will be to improve operational efficiencies and process redesign to help further drive value-based musculoskeletal care on a national level by working directly with clinical and non-clinical leadership teams.

HOPCo and Palm Beach-based The Center for Bone & Joint Surgery (CBJ), have partnered to create an innovative musculoskeletal care platform established to develop unique clinically-integrated partnerships with musculoskeletal practices and other physicians, health systems and payors throughout the Palm Beach Market, with the intent to expand the platform in other markets in South East Florida. Utilizing HOPCo’s proprietary care management platform, software tools and analytics, this new partnership will provide value-based health care solutions to improve care outcomes and patient satisfaction

HOPCo has announced the acquisition of Stryker Performance Solutions’ (SPS) BPCI-A value-based care convener business and segments of SPS’ health system orthopedic service line analytics subscription business. This acquisition now makes HOPCo one of the largest conveners of MSK bundle payment programs and the largest manager of orthopedic service lines in the country, with over 100 hospital and physician practice customers.

HOPCo announces the appointment of David Floyd to the company’s Board of Directors, effective June, 2020. David Floyd joins HOPCo with a distinguished career as an executive in the orthopedic and neurosurgical medical device industry. During his career as an executive, he successfully led medical device businesses ranging from a pre-revenue start-up to a multi-divisional corporate group with over $5 billion in revenue.